earnings
CT
NASDAQ · CTOR
Citius Oncology, Inc.
Healthcare · Drug Manufacturers - General
$0.95
Up+$0.08 (+8.51%)
Updated Sep 17, 2026, 6:53 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 96.04M
- P/E ratio
- -3.1
- Dividend yield
- 0.00%
- 52-week range
- $0.49 – $1.02
- Volume
- 184.44K
- Avg. volume
- 372.06K
Price performance
CTOR price history
1M range · 20 trading sessions · Daily adjusted prices
CTOR closed at $0.95 after 20 trading sessions, up 26.75% for the selected period.
- Last close
- $0.95
- Period change
- +26.75%
- Period low
- $0.74
- Period high
- $0.95
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.89 | $0.9839 | $0.8533 | $0.9538 | 184.44K |
| Sep 15, 2026 | $0.95 | $0.9779 | $0.8502 | $0.856 | 118.27K |
| Sep 14, 2026 | $0.9201 | $0.9883 | $0.9145 | $0.94 | 69.27K |
| Sep 11, 2026 | $0.89 | $0.95 | $0.89 | $0.9175 | 138.26K |
| Sep 10, 2026 | $0.92 | $0.94 | $0.8684 | $0.91 | 49.44K |
| Sep 9, 2026 | $0.91 | $0.9599 | $0.8583 | $0.94 | 56.5K |
| Sep 8, 2026 | $0.913 | $0.94 | $0.8715 | $0.9291 | 220.81K |
| Sep 4, 2026 | $0.7666 | $0.8816 | $0.7501 | $0.86 | 54.79K |
| Sep 3, 2026 | $0.7999 | $0.80 | $0.7778 | $0.7922 | 13.95K |
| Sep 2, 2026 | $0.735 | $0.80 | $0.7252 | $0.7777 | 12.12K |
| Sep 1, 2026 | $0.7701 | $0.7771 | $0.7245 | $0.75 | 16.59K |
| Aug 31, 2026 | $0.82 | $0.82 | $0.7529 | $0.7632 | 38.71K |
| Aug 28, 2026 | $0.80 | $0.80 | $0.7538 | $0.7756 | 21.7K |
| Aug 27, 2026 | $0.8275 | $0.83 | $0.7903 | $0.7903 | 8.57K |
| Aug 26, 2026 | $0.7908 | $0.82 | $0.7516 | $0.7871 | 17.08K |
| Aug 25, 2026 | $0.705 | $0.818 | $0.705 | $0.8101 | 134.13K |
| Aug 24, 2026 | $0.759 | $0.76 | $0.7222 | $0.75 | 16.69K |
| Aug 21, 2026 | $0.721 | $0.7549 | $0.721 | $0.7438 | 13.46K |
| Aug 20, 2026 | $0.7524 | $0.7734 | $0.71 | $0.7591 | 52.09K |
| Aug 19, 2026 | $0.73 | $0.78 | $0.6801 | $0.7525 | 58.03K |
Latest CTOR news
The latest Smart Investors Daily articles mentioning CTOR.
Stock researchResearch & News · SEC Filings
Loading stock research…